Premise: After receipt of these comments, FDA will publish a notice in the Federal Register when the agency is submitting the collections to OMB for approval and again when OMB makes a decision on approval, modification or disapproval.

Hypothesis: The comments received are not the only reason for the FDA to publish a notice.
Relation: neutral